Most Recent
Biotechs to battle in Federal Court over ‘Access’ trade marks
Intellectual Property 2020-02-05 2:49 pm By Cat Fredenburgh

Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company’s ‘Access’ trade mark is likely to confuse consumers.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Judge tosses Vagisil maker’s challenge to European rival’s trade mark
Intellectual Property 2020-02-04 11:43 am By Miklos Bolza

The international company behind the Vagisil feminine hygiene brand has lost its bid to stop a European competitor from registering Vagisan as a trade mark in Australia.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

FWC dismisses case after Facebook pics show ‘agoraphobic’ beautician sunning it up
Employment 2020-01-28 8:30 pm By Miklos Bolza

The Fair Work Commission has dismissed a general protections dispute brought by an “agoraphobic” beautician after social media posts revealed an active social life including gin, Greek food and the Melbourne Cup.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Bupa takes regulator to court as it fights ACCC allegations it overcharged, misled residents
Competition & Consumer Protection 2020-01-21 10:04 pm By Christine Caulfield

Bupa has launched court action to block a directive by the Aged Care Quality and Safety Commission as the aged care provider battles a separate case by the ACCC over payments allegedly charged to residents for services they did not receive.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Biosimilar drug makers settle IP spat over arthritis drug Humira
Intellectual Property 2020-01-21 2:21 pm By Christine Caulfield

German drug company Fresenius Kadi has resolved a patent case brought by Korean drug company Samsung Bioepis over a biosimilar of top selling arthritis drug Humira.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ATO appeals ruling in $60M dispute with Healius over lump sum payments
Appeals 2020-01-15 12:24 pm By Miklos Bolza

The Australian Taxation Office has appealed a Federal Court judgment that healthcare company Healius could recover a tax refund and associated interest estimated to be worth about $60 million.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Trial date vacated again in Country Care criminal cartel case
Competition & Consumer Protection 2019-12-19 11:43 pm By Cat Fredenburgh

A judge has vacated an upcoming trial date in a criminal cartel proceeding against mobile equipment provider Country Care Group and two individuals, and allowed the defendants to appeal a first-of-its-kind ruling on jury directions in criminal cartel cases.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Pelvic mesh cases remind judge of the days when ‘mobile phones resembled house bricks’
Class Actions 2019-12-18 10:52 pm By Miklos Bolza

A Federal Court judge has frowned on a bid to transfer 12 individual cases over allegedly defective pelvic mesh to various state and territory courts, saying the manner in which the cases had been brought reminded him of the 1990’s when “mobile phones resembled house bricks” and suggesting the cases could be brought as a class action.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Gilead says Glaxo venture’s HIV patent invalid
Intellectual Property 2019-12-10 11:57 pm By Cat Fredenburgh

US biotech giant Gilead has struck back at a patent infringement lawsuit brought by a specialist HIV pharmaceutical company majority owned by GlaxoSmithKline, saying the patent at the centre of the lawsuit is invalid.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Court approves settlement in NSW ambulance privacy class action
Class Actions 2019-12-10 4:12 pm By Miklos Bolza

The NSW Supreme Court has approved a settlement in Australia’s first privacy class action, which was brought against the NSW government over a data breach by a contractor who sold private details of 130 ambulance workers to personal injury law firms, including Bannister Law.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.